Results 11 to 20 of about 48,911 (308)

Inhaled corticosteroids for cystic fibrosis [PDF]

, 2016
Background Reduction of lung inflammation is one of the goals of cystic fibrosis therapy. Inhaled corticosteroids are often used to treat children and adults with cystic fibrosis.
Balfour-Lynn, Ian M, Welch, Karen
core   +3 more sources

Inhaled corticosteroids for bronchiectasis [PDF]

Cochrane Database of Systematic Reviews, 2018
Bronchiectasis is being increasingly diagnosed and recognised as an important contributor to chronic lung disease in both adults and children in high- and low-income countries. It is characterised by irreversible dilatation of airways and is generally associated with airway inflammation and chronic bacterial infection.
Kapur, Nitin, Petsky, Helen L., Bell, Scott, Kolbe, John, Chang, Anne B.   +4 more
openaire   +3 more sources

Inhaled Corticosteroids [PDF]

Journal of Allergy and Clinical Immunology, 2003
The Journal of Allergy and Clinical Immunology 112 (2003) S1-S40.
'Division of Endocrinology, University of Wisconsin Children''s Hospital, Madison, Wis, USA' ( host institution ), Allen, David B., Bielory, Leonard, Derendorf, Hartmut, Dluhy, Robert, Colice, Gene L., Szefler, Stanley J.   +6 more
openaire   +2 more sources

Inhaled corticosteroids in COPD: a case in favour [PDF]

European Respiratory Journal, 2009
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, which is characterised by reduced post-bronchodilator lung function in all patients 1. Although hyperresponsiveness and acute bronchodilator reversibility have been regarded as characteristics of asthma, it is now generally acknowledged that these clinical features are also ...
Postma, D. S., Calverley, P.
openaire   +2 more sources

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease [PDF]

, 2011
Background Long-acting beta2-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However,
David J Evans, Spencer, Sally, Spencer, S, Evans, David, Karner, C, Cates, CJ, Charlotta Karner, Christopher J Cates, Sally Spencer, Karner, Charlotta, Evans, DJ, Cates, Christopher, Spencer, Sally; id_orcid   +12 more
core   +1 more source

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands [PDF]

, 2006
Objective: Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands. Methods: In the Netherlands, health professionals and patients
van Puijenbroek, E; id_orcid, van Puijenbroek, E, de Vries, T.W., de Jong-van den Berg, L.T.W., de Langen-Wouterse, J J, L. T. W. de Jong-Van den Berg, T. W. de Vries, E. J. Duiverman, J. J. de Langen-Wouterse, de Jong-Van den Berg, L T W, Langen-Wouterse, J.J., van Puijenbroek, E., Duiverman, E.J., Duiverman, E J, E. van Puijenbroek   +14 more
core   +1 more source

Risks and benefits of asthma therapies

Allergology International, 2000
Maintenance use of short-acting adrenergic agents can cause tachyphylaxis, increased non-specific bronchial hyperreactivity, poorer clinical control, a worsened late allergic reaction and possibly an increased risk of death; therefore, 'as needed' use is
Peter König
doaj   +1 more source

Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy setting

SAGE Open Medicine, 2015
Objectives: The use of inhaled corticosteroids is the standard maintenance therapy in asthma therapy and as adjunct therapy in moderate to severe chronic obstructive pulmonary disease.
Valerie Chan, Andrew J Cave, Hoan Linh Banh   +2 more
doaj   +1 more source

Study of effect of inhaled versus oral corticosteroids on sputum granzyme B in patients with moderate persistent bronchial asthma

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Background: Asthma is a major public health problem with a high economic burden. It involves several inflammatory cells and multiple mediators. Granzyme B is an inflammatory mediator expressed and secreted by both immune and non immune cells. Recently it
Walaa K. Shoeib, Mahmoud M. Alsalahy, Mohammad A. Almahdy, Tarek S. Essawy, Khalid M. Belal   +4 more
doaj   +1 more source

Withdrawal of inhaled corticosteroids in COPD [PDF]

European Respiratory Journal, 2020
ICS can be withdrawn in COPD patients without history of exacerbationshttps://bit.ly ...
James D. Chalmers, Marc Miravitlles
openaire   +4 more sources